These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8280948)

  • 1. Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro.
    Huesca M; Gold B; Sherman P; Lewin P; Lingwood C
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):244-52. PubMed ID: 8280948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
    Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum.
    Bitzan MM; Gold BD; Philpott DJ; Huesca M; Sherman PM; Karch H; Lissner R; Lingwood CA; Karmali MA
    J Infect Dis; 1998 Apr; 177(4):955-61. PubMed ID: 9534968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro.
    Gold BD; Huesca M; Sherman PM; Lingwood CA
    Infect Immun; 1993 Jun; 61(6):2632-8. PubMed ID: 8500901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori.
    Roine RP; Salmela KS; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Life Sci; 1992; 51(21):PL195-200. PubMed ID: 1435071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.
    Sandha GS; LeBlanc R; Van Zanten SJ; Sitland TD; Agocs L; Burford N; Best L; Mahoney D; Hoffman P; Leddin DJ
    Dig Dis Sci; 1998 Dec; 43(12):2727-32. PubMed ID: 9881506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ranitidine bismuth citrate on Helicobacter pylori motility, morphology and survival.
    Worku ML; Sidebotham RL; Karim QN
    Aliment Pharmacol Ther; 1999 Jun; 13(6):753-60. PubMed ID: 10383504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs.
    Wagner S; Beil W; Mai UE; Bokemeyer C; Meyer HJ; Manns MP
    Pharmacology; 1994 Oct; 49(4):226-37. PubMed ID: 7831386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis.
    Ottlecz A; Romero JJ; Lichtenberger LM
    Aliment Pharmacol Ther; 1999 Jul; 13(7):875-81. PubMed ID: 10383521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients.
    Seppälä K; Färkkilä M; Nuutinen H; Hakala K; Väänänen H; Rautelin H; Kosunen TU
    Scand J Gastroenterol; 1992 Nov; 27(11):973-6. PubMed ID: 1455197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yachi A; Yokota K; Hirai Y; Oguma K; Fujii N
    J Gastroenterol; 1997 Oct; 32(5):593-7. PubMed ID: 9349983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.